Trastuzumab and chemotherapy improved survival in HER2-postive breast and brain cancer patients
Monday, July 18, 2011 - 09:30
in Health & Medicine
The use of trastuzumab, chemotherapy and surgery among women with HER2-positive metastatic breast cancer significantly improved survival from the time central nervous system metastases were diagnosed.